IL66651A - 1alpha,25-dihydroxy-24-fluoro-cholecalciferol,its manufacture and pharmaceutical compositions containing it - Google Patents

1alpha,25-dihydroxy-24-fluoro-cholecalciferol,its manufacture and pharmaceutical compositions containing it

Info

Publication number
IL66651A
IL66651A IL66651A IL6665182A IL66651A IL 66651 A IL66651 A IL 66651A IL 66651 A IL66651 A IL 66651A IL 6665182 A IL6665182 A IL 6665182A IL 66651 A IL66651 A IL 66651A
Authority
IL
Israel
Prior art keywords
cholecalciferol
manufacture
1alpha
dihydroxy
fluoro
Prior art date
Application number
IL66651A
Other versions
IL66651A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Priority to IL7652382A priority Critical patent/IL76523A/en
Priority to IL7652482A priority patent/IL76524A/en
Publication of IL66651A0 publication Critical patent/IL66651A0/en
Priority to IL76524A priority patent/IL76524A0/en
Priority to IL76523A priority patent/IL76523A0/en
Publication of IL66651A publication Critical patent/IL66651A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34—Halogenated alcohols
    • C07C31/42—Polyhydroxylic acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A cholecalciferol derivative of the formula see diagramm : EP0073465,P14,F3 1. Claims for the contracting state : AT A process for the manufacture of a cholecalciferol derivative of the formula see diagramm : EP0073465,P16,F1 characterized by thermally isomerizing a precholecalciferol derivative of the formula see diagramm : EP0073465,P16,F3
IL66651A 1981-08-28 1982-08-26 1alpha,25-dihydroxy-24-fluoro-cholecalciferol,its manufacture and pharmaceutical compositions containing it IL66651A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL7652382A IL76523A (en) 1981-08-28 1982-08-26 1,3,25-trihydroxy-24-fluoro-cholestene esters
IL7652482A IL76524A (en) 1981-08-28 1982-08-26 1,3,25-trihydroxy-24-fluoro-cholestene derivatives
IL76524A IL76524A0 (en) 1981-08-28 1985-09-27 Cholestene derivative
IL76523A IL76523A0 (en) 1981-08-28 1985-09-27 Cholestene derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29744681A 1981-08-28 1981-08-28

Publications (2)

Publication Number Publication Date
IL66651A0 IL66651A0 (en) 1982-12-31
IL66651A true IL66651A (en) 1986-03-31

Family

ID=23146345

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66651A IL66651A (en) 1981-08-28 1982-08-26 1alpha,25-dihydroxy-24-fluoro-cholecalciferol,its manufacture and pharmaceutical compositions containing it

Country Status (12)

Country Link
EP (1) EP0073465B1 (en)
JP (1) JPS5852268A (en)
AT (1) ATE17848T1 (en)
AU (1) AU559509B2 (en)
CA (1) CA1189537A (en)
DE (1) DE3268960D1 (en)
DK (1) DK154644C (en)
IE (1) IE53831B1 (en)
IL (1) IL66651A (en)
NZ (1) NZ201702A (en)
PH (1) PH21625A (en)
ZA (1) ZA826210B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55801B1 (en) * 1982-07-26 1991-01-16 Wisconsin Alumni Res Found Novel vitamin d analogs
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
JPS6045516A (en) * 1983-08-02 1985-03-12 Kureha Chem Ind Co Ltd Physiologically active agent containing 1alpha- hydroxyvitamin d3
KR100756823B1 (en) * 2001-10-23 2007-09-07 주식회사 엘지생활건강 Polyethoxylated cholecalciferol derivatives and its preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51100056A (en) * 1975-02-28 1976-09-03 Chugai Pharmaceutical Co Ltd 1 arufua 255 jihidorokishikorekarushifuerooruno seiho
JPS5576858A (en) * 1978-12-04 1980-06-10 Teijin Ltd 24-fluoro-25-hydroxyvitamin d3 or its oh-protected derivative, and their preparation
JPS55111462A (en) * 1979-02-19 1980-08-28 Sachiko Yamada Novel vitamin d3 derivative and its preparation
JPS55111460A (en) * 1979-02-16 1980-08-28 Sachiko Yamada Novel vitamin d3 derivative and its preparation
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4201881A (en) * 1979-03-28 1980-05-06 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol

Also Published As

Publication number Publication date
ZA826210B (en) 1983-07-27
DK154644C (en) 1989-05-01
DK386082A (en) 1983-03-01
CA1189537A (en) 1985-06-25
DK154644B (en) 1988-12-05
AU8779682A (en) 1983-03-03
AU559509B2 (en) 1987-03-12
EP0073465B1 (en) 1986-02-05
JPS5852268A (en) 1983-03-28
IE822083L (en) 1983-02-28
EP0073465A2 (en) 1983-03-09
IE53831B1 (en) 1989-03-15
PH21625A (en) 1987-12-11
ATE17848T1 (en) 1986-02-15
NZ201702A (en) 1985-08-16
IL66651A0 (en) 1982-12-31
DE3268960D1 (en) 1986-03-20
EP0073465A3 (en) 1983-06-08

Similar Documents

Publication Publication Date Title
DE3175042D1 (en) 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives
ZA813555B (en) 2-(halogenomethyl-phenyl)-4-halogeno-oxazole derivatives,a process for the preparation thereof,and radiation-sensitive compositions containing these derivatives
YU104382A (en) Process for the manufcture of substituted 1,2-diaminocyclo-butene-3,4-diones
IL58643A (en) Process for the preparation of 1-hydroxylated vitamin d compounds and pharmaceutical compositions comprising a 1 alpha-hydroxy-5,6-cis-bitamin d compound
YU147479A (en) Process for preparing 14,15-methylene derivatives of the estrane series
OA06486A (en) Process for the preparation of 9 aminoalkylfluorenes.
IL66651A (en) 1alpha,25-dihydroxy-24-fluoro-cholecalciferol,its manufacture and pharmaceutical compositions containing it
PH17879A (en) Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-beta-congeners
DE2961985D1 (en) A process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene
DE2861247D1 (en) Novel prostaglandin compounds, processes for the preparation thereof and pharmaceutical compositions containing them
SG37283G (en) A process for the preparation of 1,5-dimethyl-bicyclo(3.2.1)octanol-8
ZA791048B (en) Process for the preparation of a 1,2-dioxime
DE3262022D1 (en) Process for the synthesis of trialkyl-tris(3,5-dialkyl-4-hydroxybenzyl) benzene
DE3065467D1 (en) Processes for the production of 1,2,3-trihydroxyphenyl compounds
DE2964121D1 (en) Process for the preparation of muscone; the intermediate pyranic compounds
FR2393033A1 (en) PROCESS FOR PREPARING A BIS-AZOMETHINIC PIGMENT
OA06879A (en) Process for the preparation of heteroprostaglandin derivatives.
DE2964138D1 (en) Processes for the preparation of 3-azabicyclo(3.1.0)hexane derivatives
GB2013663B (en) Process for the production of 2,4-difluoro-6-amino-s-triazine
DE3067029D1 (en) Process for the preparation of 2,2'-imino-bis benzothiazole compounds
JPS57158754A (en) Improvement on organic compounds
HU182232B (en) Composition for the regulation of yield of horticulture plants
DE3060478D1 (en) Process for the preparation of 1,6-diaminonaphthalene-4,8-disulphonic acid
DE3264671D1 (en) Process for the preparation of 1,1,1-trichloromethyl compounds
AU565183B2 (en) 3-amino-1-phenoxy-2-propanol derivatives